Q99683 (M3K5_HUMAN) Homo sapiens (Human)
Mitogen-activated protein kinase kinase kinase 5 UniProtKBInterProSTRINGInteractive Modelling
1374 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of 14-3-3 zeta in complex with ASK1 14-3-3 binding motif |
Heteromer P63104; | |||||
| Assess | ||||||
| Cryo-EM structure of C-terminally truncated Apoptosis signal-regulating kinase 1 (ASK1) | homo-2-mer | |||||
| Assess | ||||||
| ASK1 kinase domain in complex with GS-4997 | homo-2-mer | 2×NJV; 2×ACT; | ||||
| Assess | ||||||
| ASK1 kinase domain complex with inhibitor | homo-2-mer | 2×KK7; | ||||
| Assess | ||||||
| Structure of mitogen-activated protein kinase kinase kinase 5 | homo-2-mer | 2×STU; | ||||
| Assess | ||||||
| ASK1 kinase domain complex with inhibitor | homo-2-mer | 2×KK8; | ||||
| Assess | ||||||
| ASK1 kinase domain complex with inhibitor | homo-2-mer | 2×S0L; | ||||
| Assess | ||||||
| Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibit… | homo-2-mer | 2×IM6; | ||||
| Assess | ||||||
| ASK1 kinase domain in complex with Compound 11 | homo-2-mer | 2×NKJ; 1×MG; | ||||
| Assess | ||||||
| Structure of the ASK1 central regulatory region | monomer | |||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 1×BH9; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 1×GOL; 1×IE6; | ||||
| Assess | ||||||
| Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure | monomer | 1×8GY; | ||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 2×IE4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 6) | monomer | 1×9E1; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13) | monomer | 1×9E4; | ||||
| Assess | ||||||
| Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure | monomer | 1×8GS; | ||||
| Assess | ||||||
| Structure of ASK1 bound to BIO-1772961 | monomer | 1×DMS; 1×RFG; | ||||
| Assess | ||||||
| Ask1 bound to compound 3 | monomer | 1×DMS; 1×EDO; 1×RFG; | ||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 1×IEO; 2×GOL; 2×ACT; | ||||
| Assess | ||||||
| Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and … | monomer | 1×V3S; | ||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 1×ACT; 1×IE8; | ||||
| Assess | ||||||
| Crystal Structures of Ask1-inhibitor Complexes | monomer | 1×STU; 1×GOL; | ||||
| Assess | ||||||
| Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization str… | monomer | 1×8V7; | ||||
| Assess | ||||||
| Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure | monomer | 1×SO4; 1×8GV; | ||||
| Assess | ||||||
| Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization str… | monomer | 1×8V4; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8qgy.1.A | homo-2-mer | 0.70 | 99.66 | |||
| Assess | ||||||
| 8jfk.1.J | monomer | 0.55 | 22.49 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 8jfk.1.J | monomer | 0.54 | 22.90 | ||
| Assess | ||||||